Wattles (Cutaneous Warts) – A Complete Patient‑Friendly Guide
Overview
Cutaneous warts—commonly called wattles—are benign skin growths caused by infection with certain types of human papillomavirus (HPV). They appear as small, rough, flesh‑colored or brownish bumps that can develop on almost any skin surface, most often on the hands, fingers, elbows, knees, and feet.
- Who it affects: All ages can develop warts, but they are most common in children and adolescents (approximately 10 % of school‑aged children in the United States have at least one wart) [1]. Immunocompromised individuals (e.g., organ‑transplant recipients, HIV patients) are also at higher risk.
- Prevalence: Worldwide, HPV‑induced cutaneous warts affect an estimated 20–30 % of the general population at some point in life [2]. In the U.S., roughly 7 million people seek medical care for warts each year.
Symptoms
While warts are generally painless, their appearance and texture can vary widely depending on the HPV type and location.
Typical clinical features
- Common warts (verruca vulgaris): Rough, dome‑shaped papules, 1–10 mm in diameter, often on the hands or fingers.
- Flat warts (verruca plana): Smooth, flat‑topped lesions, 2–5 mm, usually on the face, neck, or legs.
- Plantar warts: Hard, thickened plaques on the soles of the feet; may cause pressure pain when walking.
- Filiform warts: Long, narrow projections, commonly on the eyelids, neck, or around the mouth.
- Periungual warts: Grow around nail folds, potentially causing nail distortion.
Associated symptoms
- Small black dots (thrombosed capillaries) visible within the wart.
- Itching or mild tenderness, especially when the wart is irritated.
- Occasional bleeding if the wart is scratched or cut.
- Hyperkeratotic (thickened) skin surrounding plantar warts, leading to callus formation.
Causes and Risk Factors
Warts are caused by infection with specific HPV subtypes that preferentially infect keratinizing epithelium. The most common types include HPV‑1, 2, 4, 27, and 57.
How infection occurs
- Direct skin‑to‑skin contact with an infected person.
- Contact with contaminated surfaces (e.g., gym mats, swimming pool decks).
- Micro‑abrasions or cuts that allow the virus to enter the epidermis.
Risk factors
- Age: Children 5–12 years have the highest incidence.
- Immune status: Weakened immunity (HIV, chemotherapy, steroids) increases susceptibility and can lead to more extensive warts.
- Skin integrity: Frequent cuts, athlete’s foot, or eczema provide entry points.
- Moist environments: Warm, damp places promote viral survival on surfaces.
- Personal habits: Nail‑biting, picking at existing warts, or sharing personal items (towels, razors).
Diagnosis
Diagnosis is primarily clinical, based on visual inspection and patient history.
- Physical examination: A health‑care provider evaluates size, shape, location, and the presence of characteristic black dots.
- Dermoscopy: Handheld magnification may reveal the “frog‑spotted” pattern typical of warts.
- Biopsy: Reserved for atypical lesions that do not respond to treatment, or when carcinoma is a concern.
- HPV typing: PCR or DNA‑based tests are rarely needed but can be performed in research or in immunocompromised patients with persistent warts.
Treatment Options
Because warts are benign, treatment is often pursued for cosmetic reasons, pain, or to prevent spread. Options range from over‑the‑counter (OTC) topical agents to office‑based procedures.
Topical medications
- Salicylic acid (SA) preparations: 17–40 % SA pads, gels, or liquid; applied daily after soaking the wart. SA works by keratolysis, gradually peeling the lesion. Success rates 50–70 % after 12 weeks [3].
- Retinoids (e.g., tretinoin 0.025 %): Promote epidermal turnover; useful for flat warts.
- Cantharidin: A blistering agent applied by a clinician; leads to painless detachment of the wart after 24–48 h.
Procedural therapies
- Cryotherapy: Liquid nitrogen applied for 10–20 seconds; causes rapid freezing and destruction. Multiple sessions (2–4) often needed; cure rates 60–80 % [4].
- Electrosurgery & curettage: The wart is shaved off with a small electric loop, then the base is cauterized. Effective for resistant lesions.
- Laser therapy: Pulsed dye or CO₂ laser ablates wart tissue; reserved for refractory cases.
- Immune‑modulating injections: Intralesional bleomycin or Candida antigen can stimulate a local immune response.
- Imiquimod cream (5 %): Topical immune response modifier; data for cutaneous warts are mixed, but may help in immunocompromised patients.
Alternative & home remedies (use with caution)
- Apple‑cider vinegar, duct tape occlusion, or tea tree oil have anecdotal support but limited high‑quality evidence. They may cause skin irritation.
Lifestyle considerations
- Avoid picking or scratching warts to reduce spread.
- Keep feet dry and wear flip‑flops in communal showers to prevent plantar warts.
- Seal minor cuts promptly with antiseptic and bandage.
Living with Wattles (cutaneous warts)
Most people manage warts without major disruption, but consistent care can lessen discomfort and transmission.
Daily management tips
- Hygiene: Wash hands frequently; use separate towels for affected areas.
- Protection: Cover warts with a bandage or plaster during sports or when using communal equipment.
- Soaking: Soak warts in warm water for 5–10 minutes before applying SA to improve penetration.
- Follow‑up: Keep a treatment log (date, method, side effects) and schedule follow‑up with your clinician if lesions persist beyond 3–4 months.
Psychosocial aspects
Visible warts can cause embarrassment, especially on the face or hands. Counseling, support groups, or referral to a dermatologist for cosmetic treatment (laser, excision) can improve quality of life.
Prevention
Because HPV is ubiquitous, complete elimination is impossible, but risk can be markedly reduced.
- Do not share personal items such as towels, razors, or nail clippers.
- Wear protective footwear (flip‑flops) in pools, gyms, and locker rooms.
- Maintain skin integrity—use moisturizers for dry, cracked skin and treat athlete’s foot promptly.
- For children, discourage nail‑biting and picking at existing warts.
- Immunocompromised patients should discuss prophylactic HPV vaccination with their provider; while the vaccine covers high‑risk genital HPV, it also reduces some cutaneous HPV types.
Complications
Although warts are benign, complications can arise if they are ignored or improperly treated.
- Secondary bacterial infection: Scratching can introduce Staphylococcus or Streptococcus, leading to cellulitis.
- Painful plantar warts: May impair walking, cause callus formation, or lead to gait abnormalities.
- Nail dystrophy: Periungual warts can distort nail growth, causing permanent nail changes.
- Spread to other body sites: Autoinoculation can produce multiple warts.
- Rare malignant transformation: Certain high‑risk HPV types (e.g., 16, 18) are linked to squamous cell carcinoma, but this is exceedingly uncommon for cutaneous warts [5].
When to Seek Emergency Care
- Rapid swelling, redness, or warmth around a wart suggesting cellulitis.
- Severe pain that is not relieved by over‑the‑counter analgesics.
- Fever, chills, or feeling generally unwell together with a worsening skin lesion.
- Signs of an allergic reaction after a treatment (e.g., difficulty breathing, hives, swelling of the face or throat).
These symptoms may indicate a serious infection or an adverse reaction that requires immediate medical attention.
References
- Mayo Clinic. “Warts.” Updated 2023. https://www.mayoclinic.org/diseases-conditions/warts/symptoms-causes/syc-20353870
- World Health Organization. “Human papillomavirus (HPV) and diseases.” 2022. https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-diseases
- American Academy of Dermatology. “Wart treatment: Salicylic acid.” 2021. https://www.aad.org/public/diseases/a-z/warts-treatment
- Cleveland Clinic. “Cryotherapy for warts.” 2023. https://my.clevelandclinic.org/health/treatments/17435-cryotherapy
- National Institutes of Health. “HPV and skin cancer.” 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585225/